TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL MEDICAL INDUSTRY MARKET, BY TYPE
6.1. Overview
6.2. Therapeutic
6.3. Diagnostic
7. GLOBAL MEDICAL INDUSTRY MARKET, BY END USER
7.1. Overview
7.2. Hospitals
7.3. Clinics
8. GLOBAL MEDICAL INDUSTRY MARKET, BY REGION
8.1. Overview
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. UK
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. India
8.3.3. Japan
8.3.4. South Korea
8.3.5. Australia
8.3.6. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Middle East
8.4.2. Africa
8.4.3. Latin America
9. COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Competitive Analysis
9.3. Market Share Analysis
9.4. Major Growth Strategy in the Global Medical Industry Market,
9.5. Competitive Benchmarking
9.6. Leading Players in Terms of Number of Developments in the Global Medical Industry Market,
9.7. Key developments and Growth Strategies
9.7.1. New Product Launch/Service Deployment
9.7.2. Merger & Acquisitions
9.7.3. Joint Ventures
9.8. Major Players Financial Matrix
9.8.1. Sales & Operating Income, 2023
9.8.2. Major Players R&D Expenditure. 2023
10. COMPANY PROFILES
10.1. MEDTRONIC (IRELAND)
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Products Offered
10.1.4. Key Developments
10.1.5. SWOT Analysis
10.1.6. Key Strategies
10.2. GENERAL ELECTRIC (US)
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Products Offered
10.2.4. Key Developments
10.2.5. SWOT Analysis
10.2.6. Key Strategies
10.3. SIEMENS HEALTHINEERS (GERMANY)
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Products Offered
10.3.4. Key Developments
10.3.5. SWOT Analysis
10.3.6. Key Strategies
10.4. PHILIPS HEALTHCARE (NETHERLANDS)
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Products Offered
10.4.4. Key Developments
10.4.5. SWOT Analysis
10.4.6. Key Strategies
10.5. BECTON, DICKINSON AND COMPANY (US)
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Products Offered
10.5.4. Key Developments
10.5.5. SWOT Analysis
10.5.6. Key Strategies
10.6. BAXTER INTERNATIONAL (US)
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Products Offered
10.6.4. Key Developments
10.6.5. SWOT Analysis
10.6.6. Key Strategies
10.7. ROCHE DIAGNOSTICS (SWITZERLAND)
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Products Offered
10.7.4. Key Developments
10.7.5. SWOT Analysis
10.7.6. Key Strategies
10.8. ABBOTT LABORATORIES (US)
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Products Offered
10.8.4. Key Developments
10.8.5. SWOT Analysis
10.8.6. Key Strategies
10.9. Zimmer Biomet Holdings (US)
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Products Offered
10.9.4. Key Developments
10.9.5. SWOT Analysis
10.9.6. Key Strategies
10.10. THERMO FISHER SCIENTIFIC (US)
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Products Offered
10.10.4. Key Developments
10.10.5. SWOT Analysis
10.10.6. Key Strategies
10.11. Stryker Corporation (US)
10.11.1. Company Overview
10.11.2. Financial Overview
10.11.3. Products Offered
10.11.4. Key Developments
10.11.5. SWOT Analysis
10.11.6. Key Strategies
10.12. Danaher Corporation (US)
10.12.1. Company Overview
10.12.2. Financial Overview
10.12.3. Products Offered
10.12.4. Key Developments
10.12.5. SWOT Analysis
10.12.6. Key Strategies
10.13. Cardinal Health (US)
10.13.1. Company Overview
10.13.2. Financial Overview
10.13.3. Products Offered
10.13.4. Key Developments
10.13.5. SWOT Analysis
10.13.6. Key Strategies
11. APPENDIX
11.1. References
11.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL MEDICAL INDUSTRY MARKET, SYNOPSIS, 2019–2032
TABLE 2 GLOBAL MEDICAL INDUSTRY MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 5 NORTH AMERICA: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 7 US: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 8 US: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 9 CANADA: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 10 CANADA: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 3 GERMANY: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 5 FRANCE: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 6 FRANCE: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 7 ITALY: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 8 ITALY: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 9 SPAIN: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 10 SPAIN: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 11 UK: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 12 UK: MEDICAL INDUSTRY MARKET, BY END UER, 2019-2032 (USD BILLION)
TABLE 13 REST OF EUROPE: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 14 REST OF EUROPE: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 15 ASIA-PACIFIC: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 16 ASIA-PACIFIC: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 17 JAPAN: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 18 JAPAN: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 19 CHINA: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 20 CHINA: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 21 INDIA: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 22 INDIA: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 23 AUSTRALIA: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 24 AUSTRALIA: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 25 SOUTH KOREA: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 26 SOUTH KOREA: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 27 REST OF ASIA-PACIFIC: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 28 REST OF ASIA-PACIFIC: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 29 REST OF THE WORLD: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 30 REST OF THE WORLD: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 31 MIDDLE EAST: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 32 MIDDLE EAST: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 33 AFRICA: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 34 AFRICA: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 35 LATIN AMERICA: MEDICAL INDUSTRY MARKET, BY TYPE, 2019-2032 (USD BILLION)
TABLE 36 LATIN AMERICA: MEDICAL INDUSTRY MARKET, BY END USER, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL MEDICAL INDUSTRY MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL MEDICAL INDUSTRY MARKET
FIGURE 4 GLOBAL MEDICAL INDUSTRY MARKET, SHARE (%), BY TYPE, 2023
FIGURE 5 GLOBAL MEDICAL INDUSTRY MARKET, SHARE (%), BY END USER, 2023
FIGURE 6 GLOBAL MEDICAL INDUSTRY MARKET, SHARE (%), BY REGION, 2023
FIGURE 7 NORTH AMERICA: MEDICAL INDUSTRY MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 EUROPE: MEDICAL INDUSTRY MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 ASIA-PACIFIC: MEDICAL INDUSTRY MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 REST OF THE WORLD: MEDICAL INDUSTRY MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 GLOBAL MEDICAL INDUSTRY MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 12 MEDTRONIC (IRELAND): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 13 MEDTRONIC (IRELAND): SWOT ANALYSIS
FIGURE 14 GENERAL ELECTRIC (US): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 GENERAL ELECTRIC (US): SWOT ANALYSIS
FIGURE 16 SIEMENS HEALTHINEERS (GERMANY): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 SIEMENS HEALTHINEERS (GERMANY): SWOT ANALYSIS
FIGURE 18 PHILIPS HEALTHCARE (NETHERLANDS): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 PHILIPS HEALTHCARE (NETHERLANDS): SWOT ANALYSIS
FIGURE 20 BECTON, DICKINSON AND COMPANY (US): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 BECTON, DICKINSON AND COMPANY (US): SWOT ANALYSIS
FIGURE 22 BAXTER INTERNATIONAL (US): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 BAXTER INTERNATIONAL (US): SWOT ANALYSIS
FIGURE 24 ROCHE DIAGNOSTICS (SWITZERLAND): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 ROCHE DIAGNOSTICS (SWITZERLAND): SWOT ANALYSIS
FIGURE 26 ABBOTT LABORATORIES (US): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 ABBOTT LABORATORIES (US): SWOT ANALYSIS
FIGURE 28 ZIMMER BIOMET HOLDINGS (US): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 ZIMMER BIOMET HOLDINGS (US): SWOT ANALYSIS
FIGURE 30 THERMO FISHER SCIENTIFIC (US): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 THERMO FISHER SCIENTIFIC (US): SWOT ANALYSIS
FIGURE 32 STRYKER CORPORATION (US): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 STRYKER CORPORATION (US): SWOT ANALYSIS
FIGURE 34 DANAHER CORPORATION (US): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 DANAHER CORPORATION (US): SWOT ANALYSIS
FIGURE 36 CARDINAL HEALTH (US): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 CARDINAL HEALTH (US): SWOT ANALYSIS